AI mobile app for hemodialysis self-management
Part of Kidney & urinary clinical trials.
This trial tests a mobile app with artificial intelligence to help people on hemodialysis learn to manage their own care. It may help you feel more in control of your treatment and daily health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have an arteriovenous fistula (AVF) – a surgical connection between an artery and a vein.
- You are currently receiving outpatient hemodialysis (dialysis treatment at a clinic or hospital).
- You have been on hemodialysis for more than 6 months.
- You own a smartphone with internet access.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a smartphone app can help people on hemodialysis manage their health better. It is for patients who are comfortable using a phone app and have been on dialysis for at least 3 months.
This trial tests if a smartphone app (via WeChat) can help people on dialysis better manage their treatment and improve quality of care. It's for adults who have been on regular dialysis for at least 3 months.
This study uses artificial intelligence to analyze electronic health records and predict how well dialysis is working. If you've been on dialysis for at least 3 months, your data could help improve future care.
This trial tests a mobile app training system to help people on peritoneal dialysis manage their treatment better. If you are doing your own dialysis and are free from current infections, you may be able to join.
This study tests a hybrid (online and in-person) education program to help people on hemodialysis feel more comfortable, confident, and in control of their own care. It compares the program to standard care to see if it improves your well-being.
This study tests if an AI-powered system can help manage premature coronary artery disease in adults aged 18 to 45. It uses a smartphone app to support treatment and improve outcomes.
Hear when a new Hemodialysis Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.